相关实验视频

Updated: Jan 15, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

在儿童ED中实施发烧婴儿指南后,腰椎穿刺利用率下降

David Guernsey^1,2, Clara Horner¹, Priyanka Patel¹

¹Department of Pediatrics.

Pediatric emergency care

|October 16, 2025

概括

2021年美国儿科学会的指导方针显著减少腰部穿刺,住院治疗,以及在发烧的婴儿抗生素的使用. 这些更新的发烧管理策略在22至28天的最小婴儿中最有效.

科学领域:

儿科急救医学儿科急救医学
传染性疾病传染性疾病
临床实践指南临床实践指南

背景情况:

60天以下婴儿发烧需要对侵入性细菌感染进行评估.
美国儿科学会 (AAP) 更新的2021年指导方针旨在减少腰部穿刺 (LP),住院和22-28天的婴儿的抗生素使用.
这项研究调查了修订后的AAP指南对发烧婴儿临床实践的影响.

研究的目的:

评估2021年AAP指南在减少22至60天的发烧婴儿腰部刺伤 (LP) 的有效性.
评估指南对住院率,住院时间和抗生素使用的影响.
分析指南的影响,特别是在新分层的22-28天的年龄组和低风险婴儿中.

主要方法:

对22-60天的发烧婴儿进行回顾性队列研究 (2019年10月至2023年9月).
数据分为指导方针之前 (2021年10月之前) 和指导方针之后 (2021年10月之后) 的队列.
主要结局:接受LP的婴儿比例;次要结局:住院,住院时间,使用抗生素.

主要成果:

在指南实施后观察到LP比例的统计显著下降 (P=0.02),在22-28天子组中保持 (P=0.002).
住院和抗生素使用也在指导方针后显著下降,在22-28天小组中也有类似的减少.
低风险婴儿的LP显著减少 (P <0.001);停留时间或29-60天的婴儿没有显著变化.

结论:

2021年AAP指南有效减少了22-60天的发烧婴儿的LP,住院和抗生素使用.
22-28天的小组体验到最显著的好处,表明风险分层的改善和侵入性干预的减少.
研究结果表明,对于发烧的婴儿来说,正面的转变是向更安全,更少的侵入性护理,尽管小样本大小需要谨慎.

关键词:

新生儿发烧新生儿发烧侵袭性细菌感染侵袭性细菌感染腰部穿刺是指腰部穿刺.严重的细菌感染.

更多相关视频

Author Spotlight: Enhancing Success of Ultrasound-Guided Neuraxial Anesthesia in Cases with Difficult Anatomy

Author Spotlight: Enhancing Success of Ultrasound-Guided Neuraxial Anesthesia in Cases with Difficult Anatomy

Published on: January 31, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...